You have reached the Web site for the Department of Pathology at the University of Colorado Denver.

 – 

Cancer Stem Cells

 – 

 – 

 – 

 – 

 – 

 – 

 – 

 – 

 – 

 – 

Langston L, Fernelius C, Wisell J, Golitz L. (2011, Oct.) Duel in Dermatopathology Resident Abstract, 252259: Ocular Oncocytoma: Report of two cases. The American Society of Dermatopathology 49th Annual Meeting, Chicago, Illinois.

Khodaee M, Langston L. A Painless Finger Mass. J Musculoskelet Neuronal Interact 2012 Sept;12(3): 189-91.

Langston L, Capocelli K. (2011, Oct.) Duel in Dermatopathology Resident Abstract, 258586: Plexiform neurofibroma of the face in a 2 year-old female: bland histology, aggressive behavior. The American Society of Dermatopathology 48th Annual Meeting, Seattle, WA.

Langston L, Gaido L. (2011, March ). Erythema nodosum leprosum: pathologic findings and diagnostic challenges.Volume 35,number 2, ISSN 1091-8663. American Society for Clinical Pathology. Check Sample Surgical Pathology II 1102-CME

Brown C, Langston L. (2010, Oct.). Not just another vegetation: A rare complication of infective endocarditis. Presented at Rocky Mountain Hospital Medicine Symposium. Denver, Colorado

Gooya M, Motamedi M, Mirhaghani L. (2003, June). Integrating Prevention and Care for Injecting Drug Users in Iran The Concept of Triangular Clinics in the Control of HIV. Presented at: National Institute on Drug Abuse (NIDA); Bethesda, MD.

Poursamimi P, Mirhaghani L. (2002, January 5). Introduction a Case of Brain Micro-abscess due to Tuberculosis. Abstract Book of 9th Iranian Congress on Infectious Disease & Tropical Medicine.

Mirhaghani L, Motevalian A. (2001, December). New strategies in Counseling, Testing and Referring (CTR) for HIV/AIDS. Presented at: 2nd National Congress of Public Health & Preventive Medicine; Kermanshah, Iran.

Poursamimi P, Mirhaghani L. (2003, January). Providing an Evidence Based Model for Blood Born Hepatitis (B and C) Surveillance in Iran. Presented at: Hepatitis Congress; Tehran, Iran.

Poursamimi P, Mirhaghani L, Zamanian N, Falahi H. (2003, Feb.) HIV/AIDS Demographics in Tehran. Presented at: 10th Iranian C​ongress on Infectious Disease & Tropical Medicine; Tehran, Iran.

 – 

 – 

 – 

 – 

Asadi A, Ghalehbandi F, Bolhari J, Ghotbi M, Mohannadkhani Sh, AlilooM, Mirhaghani L. (2004). AIDS and Prevention of substance abuse in Health care system. In Bolhanri J, Bakhshipour A. (Ed.), Practical Guide for prevention and Treatment of Substance abuse (pp. 138-164). Tehran, Iran (Islamic Republic of). Tehran Psychiatric Institute.

Daryani N, Poursamimi P, Hashtroodi A, Mirhaghani L. (2003). Hepatitis A and E. In Daryani,N., Moosavi,M. (Ed.), Hepatitis, A Guideline for Doctors (pp. 7-46). Tehran, Iran. Shabak.

Mirhaghani L, Nasehi N. (2002). Managing and Monitoring Tuberculosis. In Salek,A., Mohraz,M., Siadati,A. Masjedi,M.R., Zarifi,A.,Mansouri,D. (Ed.), National Tuberculosis Manual (pp. 9-153). Tehran, Iran. Ceneter for Disease Control, Ministry of Health.

Tabatabae M, Ghotbi M, Falahi H, Mirhaghani L, Zanganeh AM. (2002). Tuberclosis,HIV/AIDS, Hepatitis.. In Sharifian,M. (Ed.), Surveillance of Communicable Disease, A Training Manual (pp. 75-89,32-36,15-20). Tehran, Iran. Center for Disease Control (CDC).

 Email:

 Pager:

Leila.Langston@ucdenver.edu

(303) 266-3406